Subscribe To
Cyclacel pharmaceuticals announces receipt of $4.7 million r&d tax credit
BERKELEY HEIGHTS, N.J., May 03, 2023 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Compan...
May 3, 2023, 1:15 pm
Wall street analysts think revolution medicines, inc. (rvmd) could surge 27.24%: read this before placing a bet
The average of price targets set by Wall Street analysts indicates a potential upside of 27.2% in Revolution Medicines, Inc. (RVMD). While the effecti...
May 3, 2023, 11:27 am
Eterna therapeutics acquires allogeneic immuno-oncology platform from exacis biotherapeutics
Acquisition includes Exacis’ entire pipeline of engineered cell therapy programs for hematologic and solid tumors CAMBRIDGE, Mass., May 02, 2023 (GL...
May 2, 2023, 11:30 am
Bioxcel therapeutics to present at the bofa securities 2023 health care conference
NEW HAVEN, Conn., May 02, 2023 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelli...
May 2, 2023, 7:00 am
Mgc pharmaceuticals production facility granted formal gmp certification
The Malta production facility owned by MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) has been granted formal EU-Good Manufacturing Practice (G...
May 1, 2023, 10:50 pm
Catalyst pharmaceuticals announces release of inaugural esg report
CORAL GABLES, Fla., May 01, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX), a commercial-stage biopharmaceut...
May 1, 2023, 12:03 pm
Mineralys therapeutics to announce first quarter 2023 financial results and host conference call on monday, may 15, 2023
RADNOR, Pa., May 01, 2023 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on devel...
May 1, 2023, 8:00 am
Mineralys therapeutics to participate in the bank of america securities 2023 health care conference on wednesday, may 10, 2023
RADNOR, Pa., April 27, 2023 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on de...
April 27, 2023, 8:47 pm
Chinook therapeutics to present at upcoming investor conferences
SEATTLE , April 27, 2023 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, developm...
April 27, 2023, 4:00 pm
The global wild mint oil market was valued at usd 10.10 billion in 2022, is projected to grow at a cagr of 9.5% during the forecast period 2022 to 2030 | data by contrive datum insights pvt ltd.
According to a market research study published by Contrive Datum Insights, Wild Mint Oil is an essential oil that is often used to make ...
April 22, 2023, 12:31 pm
Astrazeneca results arrive with focus on drug trials, while gsk still faces zantac overhang
The FTSE 100's biggest company reports next week, AstraZeneca PLC (LSE:AZN) stepping up with a first-quarter trading update on Thursday, preceded by a...
April 21, 2023, 1:23 pm
Karuna therapeutics to announce first quarter 2023 financial results and provide general business update on thursday, may 4, 2023
BOSTON--(BUSINESS WIRE)---- $KRTX--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver t...
April 20, 2023, 6:30 am
Radiopharmaceuticals market predicted to garner $10.3 bn by 2032; at a cagr of 8.85% | market.us report
The rising popularity of diagnostic and therapeutic nuclear medicines in the radiopharmaceutical market...
April 19, 2023, 8:32 pm
Why is clearmind medicine (cmnd) stock up 47% today?
Clearmind Medicine (NASDAQ: CMND ) stock is on the rise Wednesday despite a lack of news from the psychedelic ...
April 19, 2023, 7:49 am
Kura oncology to participate in stifel targeted oncology days
SAN DIEGO, April 18, 2023 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing t...
April 18, 2023, 11:30 am
Verastem oncology to present at the stifel 2023 virtual targeted oncology days
BOSTON--(BUSINESS WIRE)--Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new ...
April 18, 2023, 7:05 am
Gsk pays £1.6bn for canada's bellus health
GSK PLC (LSE:GSK, NYSE:GSK) has paid around £1.6bn for Bellus Health (TSX:BLU) Inc, a Canada-based, late-stage biopharmaceutical company which specia...
April 18, 2023, 2:48 am
Passage bio to present at chardan's 7th annual genetic medicines and cell therapy manufacturing summit
PHILADELPHIA, April 17, 2023 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic me...
April 17, 2023, 7:00 am
Century therapeutics to present at chardan's 7th annual genetic medicines & cell therapy manufacturing virtual summit
PHILADELPHIA, April 17, 2023 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative clinical-stage biotechnology company developing in...
April 17, 2023, 7:00 am
Frontier medicines presents new preclinical data on its development candidate, fmc-376, a dual krasg12c inhibitor, at the 2023 aacr annual meeting
-FMC-376 is a highly selective, direct dual inhibitor designed to rapidly and completely block both the active and inactive forms of KRASG12C and over...
April 16, 2023, 7:00 pm